SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries.
Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from tendon-to-bone injuries.
To solve this problem, the research team, led by the Shanghai Institute of Ceramics (SIC) of the Chinese Academy of Sciences, combined manganese silicate (MS) nanoparticles with tendon/bone-related cells to construct an immunomodulatory multicellular scaffold to achieve integrated tendon-to-bone regeneration.
The scaffold not only demonstrated diverse biological activities in vitro, but also achieved immune regulation, multi-tissue integration regeneration and motor function recovery in a variety of animal models of rotator cuff injury.
The study provides a new concept for achieving immunomodulation and integrated regeneration of tendon-bone and other tissue interfaces, said Wu Chengtie with the SIC, who led the research.
The study was recently published in the journal Science Advances.
(Editor:Fu Bo)
Election 2024: Biden and Trump bypassed the Commission on Presidential Debates
11 missing in Guangdong rainstorm
IOC launches innovative Paris 2024 mobile game
China's road, water passenger trips plunge in Jan.
Uber and Lyft say they'll stay in Minnesota after Legislature passes driver pay compromise
France goalkeeper Mike Maignan injures thigh muscle ahead of the European Championship
Fireworks show held in Thailand's beach resort Pattaya to promote tourism
Italian region to halt COVID testing upon arrival from China
Biden says Brown v. Board of Education ruling was about more than education
Saudi Arabia sets ambitious tourism goal
‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
Only 35 Nanjing Massacre survivors remain